首届St Gallen国际晚期前列腺癌专家共识荟萃

发布时间：2018-01-09 01:05

本文关键词：首届St Gallen国际晚期前列腺癌专家共识荟萃　出处：《中华肿瘤防治杂志》2015年20期 　论文类型：期刊论文

【摘要】：前列腺癌治疗方面的循证医学证据较多,目前迫切需要形成共识指导临床治疗。2015-03首届国际晚期前列腺癌(advanced prostate cancer,APC)会议在欧洲小镇圣加仑(St Gallen)召开,会议专家委员会基于循证医学证据,对晚期前列腺癌的临床诊疗领域热点问题通过讨论达成共识,并对有分歧的观点作出客观评价。最终的汇总结果刊登于2015-06-28《Annals of Oncology》杂志。本年度专家共识重点内容包括晚期去势敏感性前列腺癌的治疗、寡转移性去势敏感性前列腺癌的治疗、去势抵抗的定义、非转移性(M0期)去势抵抗性前列腺癌(castration resistance prostate cancer,CRPC)的治疗、内分泌治疗、转移性CRPC的治疗策略及治疗次序和前列腺癌的多学科治疗等多个方面。本研究就去势敏感性与去势抵抗性前列腺癌的治疗以及多学科治疗进行阐述,为临床中APC的治疗提供理论指导。
[Abstract]:There is more evidence of evidence-based medicine for prostate cancer treatment. There is an urgent need for consensus to guide clinical treatment. 2015-03 the first international advanced prostate cancer for advanced prostate cancer. The APC meeting was held in St Gallen, a small European town, where the Committee of experts was based on evidence-based medical evidence. A consensus was reached on the hot issues in the field of clinical diagnosis and treatment of advanced prostate cancer. The final summary is published in Annals of 2015-06-28. Oncology >. The focus of this year's expert consensus is on the treatment of advanced castrated and sensitive prostate cancer. Treatment of oligometastatic castration sensitive prostate cancer and definition of castration resistance. Treatment of ovariectomized resistance prostate cancer (stage M0). Endocrine therapy. The strategy and sequence of treatment for metastatic CRPC and the multidisciplinary treatment of prostate cancer. This study reviews the treatment of ovariectomized and ovariectomized prostate cancer as well as the multidisciplinary treatment. To provide theoretical guidance for the treatment of APC in clinic.
【作者单位】：天津医科大学肿瘤医院介入治疗科·国家肿瘤临床医学研究中心·天津市"肿瘤防治"重点实验室;天津医科大学第二医院肿瘤科;
【基金】：国家自然科学基金(81572543) 天津市卫生行业重点公关项目(14KG141)
【分类号】：R737.25
【正文快照】： 中华肿瘤防治杂志,2015,22(20):1644-1648Chin J Cancer Prev Treat,2015,22(20):1644-1648前列腺癌是老年男性常见的恶性肿瘤。在欧美国家,前列腺癌的发病率已经超过肺癌,占第1位,其中美国前列腺癌已成为男性癌症的第2大死因[1]。在我国,随着生活习惯改变、人口老龄化、检查

【相似文献】